Pentamidine isethionate is an antifungal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment and prevention of Pneumocystis pneumonia (PCP). The FDA-approved uses for pentamidine isethionate depend on the dosage form of the drug. Specifically, pentamidine isethionate injection is approved to treat PCP, and pentamidine isethionate inhalant is approved to prevent PCP in people with HIV who are at high risk of developing PCP. It is grouped under the following drug class(es): Leishmaniasis agents and Trypanosomiasis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nebupent, Diamidine, Lomidin and Pneumopent. Its PubChem CID is 8813.
Pentamidine isethionate
| CAS No | 140-64-7 |
|---|---|
| Molecular Formula | C19H24N4O2.2C2H6O4S |
| Molecular Weight | 592.7 g/mol |
| Synonyms | 4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment and prevention of Pneumocystis pneumonia (PCP). The FDA-approved uses for pentamidine isethionate depend on the dosage form of the drug.
The listed CAS number is 140-64-7.
The listed molecular formula is C19H24N4O2.2C2H6O4S.
The listed molecular weight is 592.7 g/mol.
4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid.
The source lists Nebupent, Diamidine, Lomidin and Pneumopent.